insights_auto
Why is CMXHF up 2,22%?
Dive Deeperchevron_right
CMXHF:OTCMKTS
CSL Ltd
123,79 USD
arrow_upward
+2,22%(+2,69) 1D
15-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Open
129,22 USD
High
129,22 USD
Low
123,79 USD
Mkt. cap
92,23 млд
Avg. vol.
167,00
Volume
564,00
52-wk high
148,36 USD
52-wk low
63,84 USD
Beta
0,56
Shares outstanding
479,88 млн
No. of employees
29 миң
Open
129,22 USD
High
129,22 USD
Low
123,79 USD
Mkt. cap
92,23 млд
Avg. vol.
167,00
Volume
564,00
52-wk high
148,36 USD
52-wk low
63,84 USD
Beta
0,56
Shares outstanding
479,88 млн
No. of employees
29 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
1 күн мурун
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29 миң
Founded1916
HeadquartersМельбурн, Виктория, Австралия
Sector-
Websitecsl.com